According to GlobalData, NEXSTAT is one of 56 product lines sold in the US arteriotomy closure devices market; these product lines are sold by 21 different manufacturers. The average selling price for NEXSTAT increased in hospitals, increased in health systems, and decreased outside of hospital facilities in 2022. The price of the NEXSTAT device can be viewed in GlobalData’s micro pricing report and can be retrieved according to purchase date, facility type, bed size, and geographical region. Buy the report here.
The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches.
In addition, the final selling pricing of medical devices is also impacted by the discounting policy of the manufacturer. Companies such as Hemostasis apply discounts for their devices based on their internal business strategy, inventory control, and monthly or quarterly sales targets. In addition, sale location can also affect the final selling price of a device, both in terms of geographical region and facility type. Prices for the same medical device often vary in hospitals and health systems versus outside of hospital facilities, for example if high volume healthcare institutions can negotiate discounts or rebates based on large purchase sizes.
Hemostasis LLC (Hemostasis) is a medical device company that manufactures and designs bleeding control technology products. The company’s products include topical hemostat powder, hemostat dressing and intranasal splint, hemostat patch, topical hemostat sponge, intranasal splint, foam hemostat pad, OTC powder and foam. Its hemostat dressing and intranasal splint is a foam splint made from natural chitosan based polymer and hemostatic patch accelerates the clotting process to control bleeding. Hemostasis’ OTC powder and foam provides quick and painless solution from minor to moderate bleeding wounds. The company offers its products across the US. Hemostasis is headquartered in Saint Paul, Minnesota, the US.
For a complete picture of NEXSTAT, Arteriotomy Closure Devices pricing in the US, buy the report here.